ClinicalTrials.govpublic full text
To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
sars-cov-2 infection, covid-19, maternal immunization
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 414361
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.